Please use this identifier to cite or link to this item:
|Title:||Comparison of the TaqMan and LightCycler systems in evaluation of CYP2B6 516G>T polymorphism|
|Keywords:||Biochemistry, Genetics and Molecular Biology|
|Abstract:||Understanding genetically encoded inherited differences in drug metabolism and drug targets offers the promise of minimizing adverse drug reactions and improving therapies. We have compared two real-time PCR-based methods, the TaqMan®and LightCycler™ for the pharmacogenetic evaluation of CYP2B6 516G>T polymorphism. Both methods were found to be suitable for pharmacogenetic testing of CYP2B6 516G>T in the meaning of time consumption, accurate genotype calling, flexible reaction format, simple data analysis, and low cost per assay. The genotype success rate was similar, but the LightCycler procedure was less expensive in terms of cost per sample and shorter running time. © 2007 Elsevier Ltd. All rights reserved.|
|Appears in Collections:||CMUL: Journal Articles|
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.